- Home
- Publications
- Publication Search
- Publication Details
Title
An Inflammatory Mediator, Prostaglandin E2, in Colorectal Cancer
Authors
Keywords
-
Journal
CANCER JOURNAL
Volume 19, Issue 6, Pages 502-510
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2013-11-21
DOI
10.1097/ppo.0000000000000003
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association between Urinary Prostaglandin E2 Metabolite and Breast Cancer Risk: A Prospective, Case-Cohort Study of Postmenopausal Women
- (2013) S. Kim et al. Cancer Prevention Research
- Increased Levels of Urinary PGE-M, a Biomarker of Inflammation, Occur in Association with Obesity, Aging, and Lung Metastases in Patients with Breast Cancer
- (2013) P. G. Morris et al. Cancer Prevention Research
- Increased Th17 Cells in the Tumor Microenvironment Is Mediated by IL-23 via Tumor-Secreted Prostaglandin E2
- (2013) X. Qian et al. JOURNAL OF IMMUNOLOGY
- A prostaglandin E (PGE) receptor EP4 antagonist protects natural killer cells from PGE2-mediated immunosuppression and inhibits breast cancer metastasis
- (2013) Xinrong Ma et al. OncoImmunology
- Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials
- (2012) Peter M Rothwell et al. LANCET
- Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials
- (2012) Annemijn M Algra et al. LANCET ONCOLOGY
- Prostaglandin E2 promotes intestinal tumor growth via DNA methylation
- (2012) Dianren Xia et al. NATURE MEDICINE
- Regulation of COX2 Expression in Mouse Mammary Tumor Cells Controls Bone Metastasis and PGE2-Induction of Regulatory T Cell Migration
- (2012) John Karavitis et al. PLoS One
- Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells
- (2011) N. Obermajer et al. BLOOD
- Selective PGE2 Suppression Inhibits Colon Carcinogenesis and Modifies Local Mucosal Immunity
- (2011) M. Nakanishi et al. Cancer Prevention Research
- A Randomized Placebo-Controlled Prevention Trial of Aspirin and/or Resistant Starch in Young People with Familial Adenomatous Polyposis
- (2011) J. Burn et al. Cancer Prevention Research
- PGE2-Induced CXCL12 Production and CXCR4 Expression Controls the Accumulation of Human MDSCs in Ovarian Cancer Environment
- (2011) N. Obermajer et al. CANCER RESEARCH
- Prostaglandin E2 suppresses the differentiation of retinoic acid–producing dendritic cells in mice and humans
- (2011) Angus Stock et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
- (2011) John Burn et al. LANCET
- Prostaglandin E2-prostoglandin E receptor subtype 4 (EP4) signaling mediates UV irradiation-induced systemic immunosuppression
- (2011) K. Soontrapa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prostaglandin EP4 receptor enhances BCR-induced apoptosis of immature B cells
- (2011) Matevz Prijatelj et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Prostaglandin E2 and SOCS1 have a role in intestinal immune tolerance
- (2011) Takatoshi Chinen et al. Nature Communications
- PGE2 inhibits natural killer and γδ T cell cytotoxicity triggered by NKR and TCR through a cAMP-mediated PKA type I-dependent signaling
- (2010) Ludovic Martinet et al. BIOCHEMICAL PHARMACOLOGY
- PGE2 transiently enhances DC expression of CCR7 but inhibits the ability of DCs to produce CCL19 and attract naive T cells
- (2010) R. Muthuswamy et al. BLOOD
- COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function
- (2010) Joris D Veltman et al. BMC CANCER
- Macrophage Diversity Enhances Tumor Progression and Metastasis
- (2010) Bin-Zhi Qian et al. CELL
- COX-2 and PGE2 signaling is essential for the regulation of IDO expression by curcumin in murine bone marrow-derived dendritic cells
- (2010) In Duk Jung et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Prostaglandin E2Activates and Utilizes mTORC2 as a Central Signaling Locus for the Regulation of Mast Cell Chemotaxis and Mediator Release
- (2010) Hye Sun Kuehn et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Role for IL-1 Receptor-Associated Kinase-M in Prostaglandin E2-Induced Immunosuppression Post-Bone Marrow Transplantation
- (2010) L. L. N. Hubbard et al. JOURNAL OF IMMUNOLOGY
- Quantitative analysis of mast cells in benign and malignant colonic lesions: immunohistochemical study on formalin-fixed, paraffin-embedded tissues
- (2009) Y. Kashiwase et al. ALLERGOLOGIA ET IMMUNOPATHOLOGIA
- Urinary Prostaglandin E2 Metabolite and Gastric Cancer Risk in the Shanghai Women's Health Study
- (2009) L. M. Dong et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Elevated Levels of Urinary Prostaglandin E Metabolite Indicate a Poor Prognosis in Ever Smoker Head and Neck Squamous Cell Carcinoma Patients
- (2009) V. D. Kekatpure et al. Cancer Prevention Research
- T-Regulatory Cells Shift from a Protective Anti-Inflammatory to a Cancer-Promoting Proinflammatory Phenotype in Polyposis
- (2009) Elias Gounaris et al. CANCER RESEARCH
- Mast Cells as Target in Cancer Therapy
- (2009) Tom Kormelink et al. CURRENT PHARMACEUTICAL DESIGN
- Prostaglandin E2 enhances Th17 responses via modulation of IL-17 and IFN-γ production by memory CD4+ T cells
- (2009) Giorgio Napolitani et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Aspirin Use and Survival After Diagnosis of Colorectal Cancer
- (2009) Andrew T. Chan JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling
- (2009) Katia Boniface et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Altered Expression of 15-Hydroxyprostaglandin Dehydrogenase in Tumor-Infiltrated CD11b Myeloid Cells: A Mechanism for Immune Evasion in Cancer
- (2009) E. Eruslanov et al. JOURNAL OF IMMUNOLOGY
- Prostaglandin E2 Inhibits IFN- Secretion and Th1 Costimulation by Human Plasmacytoid Dendritic Cells via E-Prostanoid 2 and E-Prostanoid 4 Receptor Engagement
- (2009) D. Fabricius et al. JOURNAL OF IMMUNOLOGY
- Fas Signal Promotes Lung Cancer Growth by Recruiting Myeloid-Derived Suppressor Cells via Cancer Cell-Derived PGE2
- (2009) Y. Zhang et al. JOURNAL OF IMMUNOLOGY
- IL4Rα + Myeloid-Derived Suppressor Cell Expansion in Cancer Patients
- (2009) Susanna Mandruzzato et al. JOURNAL OF IMMUNOLOGY
- Tumor cell lysate-pulsed dendritic cells induce a T cell response against colon cancer in vitro and in vivo
- (2009) Yu-gang Wu et al. MEDICAL ONCOLOGY
- Prostaglandin E2–EP4 signaling promotes immune inflammation through TH1 cell differentiation and TH17 cell expansion
- (2009) Chengcan Yao et al. NATURE MEDICINE
- Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion
- (2008) C. Chizzolini et al. BLOOD
- Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy
- (2008) C. Marcela Diaz-Montero et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Genetic Deletion of mPGES-1 Suppresses Intestinal Tumorigenesis
- (2008) M. Nakanishi et al. CANCER RESEARCH
- Prevention of Both Direct and Cross-Priming of Antitumor CD8+ T-Cell Responses following Overproduction of Prostaglandin E2 by Tumor Cells In vivo
- (2008) M. Ahmadi et al. CANCER RESEARCH
- Ability of Mature Dendritic Cells to Interact with Regulatory T Cells Is Imprinted during Maturation
- (2008) R. Muthuswamy et al. CANCER RESEARCH
- Cyclooxygenase-2 Expression Is an Independent Predictor of Poor Prognosis in Colon Cancer
- (2008) S. Ogino et al. CLINICAL CANCER RESEARCH
- Prostaglandin E2 regulates B cell proliferation through a candidate tumor suppressor,Ptger4
- (2008) Jernej Murn et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Aspirin and Folic Acid for the Prevention of Recurrent Colorectal Adenomas
- (2007) Richard F.A. Logan et al. GASTROENTEROLOGY
- Prognostic significance of mast cell number and microvascular density for the survival of patients with primary colorectal cancer
- (2007) Maya Gulubova et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started